search icon
  • Print
  • ShareThis
  • Text Size
  • Letter to U.S. Preventive Services Task Force on HPTN-052

    HIVMA Board Chair, Dr. Judith A. Aberg, weighed in with the U.S. Preventive Services Task Force (USPSTF) on behalf of HIVMA, to highlight the relevance of the HPTN-052 clinical trial findings for the updated evidence review on routine HIV screening that the Task Force is currently conducting.

    We are pleased that the USPSTF is presently conducting a much needed updated evidence review of the 2006 recommendation on routine HIV screening, as noted in the Task Force’s October, 2011“Annual Report to Congress on High-Priority Gaps for Clinical Preventive Services.” I am writing on behalf of the 4,700 members of the HIV Medicine Association (HIVMA) to share what we believe are critical implications of recent U.S.-funded HIV clinical trial results for the USPSTF’s work on this critical issue.

    Read the full statement  PDF

| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site